Daily Stock Setups

VeriChip and Receptors to Develop Sensor Systems to Detect Biological Threats

Posted on: Thu, 14 May 2009 22:53:00 EDT

Symbols: CHIP

Are you looking to increase your ETF knowledge?

May 14, 2009 (Close-Up Media via COMTEX) --
CHIP | Quote | Chart | News | PowerRating -- VeriChip Corp. and its development partner Receptors, a technology company whose Affinity by Design chemistry platform can be applied to the development of selective binding products, announced plans to develop surveillance and point-of-care sensor systems that will detect and identify the presence of a particular biological threat such as influenza virus, Methicillin-resistant Staphylococcus aureus (MRSA) or other illnesses.

The companies published a white paper outlining the development of "An Integrated Sensor System for the Detection of Bio-Threats from Pandemics to Emerging Diseases to Bio-Terrorism," on VeriChip's website at verichipcorp.com.

Robert E. Carlson, Ph.D., President and CSO at Receptors, said, "Through our development partnership with VeriChip, we are focused on building an integrated suite of products that will identify a biological threat, from pandemic influenza and multiple-resistant pathogens like MRSA, to food borne illnesses such as salmonella and E. coli. The combination of our CARA platform and VeriChip's signal transduction and communication capabilities provide both the technology and the expertise required to build the integrated bio-threat sensor system."

Scott R. Silverman, Chairman of VeriChip, said, "As we continue to build on our partnership with Receptors, which started with the development of a glucose-sensing RFID implantable microchip, we are moving beyond patient identification to sensors that can detect and identify illnesses and viruses such as influenza. This is an exciting next step for the future of our healthcare division."

VeriChip has announced it has expanded its existing development partnership with Receptors, beyond the glucose-sensing RFID implantable microchip to include other biological and environmental applications. Receptors recently received Patent No. 7,504,364 titled "Methods of Making Arrays and Artificial Receptors" and Patent No. 7,469,076 "Sensors Employing Combinatorial Artificial Receptors," which are being applied to the development of diagnostic and sensor platforms for pathogens and other biologicalthreats.

((Comments on this story may be sent to newsdesk@closeupmedia.com))

For full details on Verichip Corporation (CHIP) CHIP. Verichip Corporation (CHIP) has Short Term PowerRatings at TradingMarkets. Details on Verichip Corporation (CHIP) Short Term PowerRatings is available at This Link.

More News: Market Updates | Stock Alerts | All Trading News

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.